InsidersTradesSigma
Browse the full record of transactions filed by Cravatt Benjamin, Director. Officer active across 1 companies, notably FIBROGEN INC. Cumulatively, 3 disclosures have been published. The latest transaction was disclosed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Benjamin Cravatt is a Board Member at FibroGen Inc. He brings expertise in biotechnology and corporate governance. In his role, Cravatt is involved in making strategic decisions that influence the company's direction.